Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jan 08, 2024 10:56am
61 Views
Post# 35815625

RE:RE:fossi doesn't want people to talk about it.

RE:RE:fossi doesn't want people to talk about it.Everestbaker, "Agree with you completely Fossi."
 

You agree with fossi who less than nine months ago applauded CZO's step-wise plan for PGX as the ""right" framework" and said that it was the "most promising development point" that could lead to a "rapid tripling of Ceapro's sales towards 2026".

fossi, "In the whole discussion about the pipeline of Ceapro, the development from a 10l plant to one with 50-100l is for me the most promising development point. This is where the rapid tripling of Ceapro's sales towards 2026 can be realized." April 13, 2023


The 5X PGX scale-up is now expected to be commissioned THIS QUARTER! CZO was so confident with how scale-up was going that it hired industry Natex in November to simultaneously scale 10X. In the November news release CZO disclosed industry leader Natex was working on the 10X scale-up with 50% of the equipment and infrastructure in place to secure the project. Much of the work in already in place! We are in the home stretch of the step-wise plan for PGX and CZO has potentially secured the capital for its next phase of growth with the AEZS merger. Ronnie Miller is "thrilled". AEZS's Chair has endorsed the plan and believes it provides the necessary capital. CZO is also taking its story to NASDAQ as it works on its step-wise plan. That's confidence! Raymond James and Bloom Burton have provided fairness opinions for the merger. At the AGM Gilles said it was in discussions with serious potential partners for PGX-CoQ10 who understand bioavailaiblity as a unique selling point. CZO blew away the industry gold standard in the University of Alberta study. fossi's endorsement of CZO's step-wise plan is showing important signs of success. 
<< Previous
Bullboard Posts
Next >>